Hudson Litigation Capital

01 / Solutions

Dispute Finance

Non-recourse capital for the prosecution of qualifying commercial disputes.

Capital for disputes that are still being fought. Merits, quantum, budget, timetable and the eventual path to recovery are assessed together, because a well-founded claim against an unreachable counterparty is not a financeable asset.

Submit a matterHow we invest
§ 1

What this family covers

The published solutions.

01Commercial Litigation FinanceNon-recourse capital for qualifying commercial litigation costs.02Arbitration FinanceCapital for commercial and investment arbitration, subject to elevated review where a state is involved.03Counterclaim Finance through HLCDCCapital for affirmative monetary counterclaims, provided through the separately governed affiliate.Provided through HLCDC04Collective Claims FinanceCapital for institutional and commercial group claims, under defined governance.
§ 2

Transaction context

How capital is used in this family.

Non-recourse capital for the costs of prosecuting a qualifying commercial claim. Repayment and return are payable from defined proceeds of the matter. If the claim does not produce a recovery, Hudson does not look to the claimant for repayment, save in respect of fraud and defined default remedies.

Non-recourse capital for the prosecution of commercial arbitration, and for investment arbitration where the mandate, the jurisdiction and the recovery profile support it.

HLCDC funds qualifying affirmative monetary counterclaims. It does not fund the cost of defending the underlying claim.

Capital for coordinated claims brought by a group of commercial claimants arising from substantially common facts: investors, lenders, insurers, distributors, suppliers or other institutional parties.

Where capital may be applied

  • Legal fees and disbursements of counsel of record.
  • Counsel fees and disbursements.
  • The costs of prosecuting the affirmative counterclaim.
  • The costs of prosecuting the coordinated claim.
  • Expert, quantum and forensic work.
  • Tribunal, institutional and administrative costs.
  • Expert, quantum and forensic work attributable to the counterclaim.
  • Group-wide expert, quantum and loss-schedule work.

In each case as set out in the approved commitment and the transaction documents.

§ 3

Relevant considerations

What Hudson examines.

Published considerations only. Internal underwriting methodology, pricing and return parameters are not published.

  • 01The legal merits, supported by independent review rather than by counsel enthusiasm alone.
  • 02The seat, the governing law and the arbitral institution or rules.
  • 03The counterclaim as the funded asset, on its own merits and quantum.
  • 04The claimant perimeter: who is in the group, who is represented, and on what authority.
  • 05Quantum by head of loss, and how much of it is realistically liquidated.
  • 06The tribunal appointment process and the expected timetable to award.
  • 07How the underlying claim interacts with the counterclaim: set-off, global settlement, severance and procedural linkage.
  • 08Whether the claims arise from substantially common facts.
§ 4

Counterparties

Who this family is for.

  • 01Corporates and commercial claimants with a substantial claim and represented by counsel.
  • 02Corporates and commercial claimants in institutional or ad hoc arbitration.
  • 03Corporate defendants holding a substantial affirmative counterclaim against the party that sued them.
  • 04Groups of corporate or institutional claimants pursuing a coordinated claim.
  • 05Counsel seeking an institutional funder for a client who prefers not to carry the cost of the dispute on its own balance sheet.
  • 06Counsel and arbitration practices bringing a substantial claim before a recognised institution.

Independence and published limits

Counsel and the claimant retain responsibility for litigation strategy and every professional decision. Hudson does not select, instruct or supervise counsel, and does not control settlement.

Matters involving states or state entities are not automatically eligible. They receive elevated review and are considered only where the mandate, the jurisdiction and the enforcement path support a commitment.

HLCDC carries no upfront or origination fee. It does not direct pleadings, evidence, strategy, witness decisions or settlement negotiations, and counsel selection remains the defendant-claimant's responsibility.

Published committed-capital band: USD 2m to USD 15m. Claim quantum is ordinarily USD 15m or more, which is an expectation rather than an automatic eligibility threshold. Published committed-capital band: USD 5m to USD 15m of committed capital. This is the capital commitment, not the value of the counterclaim. Counterclaim quantum is ordinarily USD 15m or more, as an expectation rather than a threshold. No capital band is published for the other solutions in this family; those parameters are transaction-specific. Certain matters outside an applicable published band may be considered by exception.

How we invest

Published parameters, by solution

Commercial Litigation Finance
Published committed-capital band: USD 2m to USD 15m. Claim quantum is ordinarily USD 15m or more, which is an expectation rather than an automatic eligibility threshold.
Counterclaim Finance through HLCDC
Published committed-capital band: USD 5m to USD 15m of committed capital. This is the capital commitment, not the value of the counterclaim. Counterclaim quantum is ordinarily USD 15m or more, as an expectation rather than a threshold.

The four families

Submit a matter for initial institutional review.

Submission does not create a funding commitment, and no fee is payable on submission. Matters are acknowledged in writing, ordinarily within one to two business days.

Submit a matterAll solutions